• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

September 2007: Additions and Deletions to the Drug Product List

27th Edition: Cumulative Supplement Number 9

Prescription     OTC

NOTE: The format for the Monthly Additions/Deletions Drug Product List changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.6 Cumulative Supplement Legend.


ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
    ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
          TABLET; ORAL
>D>         WYGESIC
>D>   AA  +   LEITNER PHARMS             650MG;65MG                              N84999 001                  Se   DISC
>A>         @                            650MG;65MG                              N84999 001                  Se   DISC

        ALBUTEROL
          AEROSOL, METERED; INHALATION
>D>         PROVENTIL
>D>   BN  +   SCHERING                   0.09MG/INH                              N17559 001                  Se   DISC
>A>         @                            0.09MG/INH                              N17559 001                  Se   DISC

        ALBUTEROL SULFATE
          SOLUTION; INHALATION
            ACCUNEB
>D>       +   DEY                        EQ 0.021% BASE                          N20949 002  Apr 30, 2001    Se   CFTG
>A>   AN  +                              EQ 0.021% BASE                          N20949 002  Apr 30, 2001    Se   CFTG
>A>         ALBUTEROL SULFATE
>A>   AN      WATSON LABS                EQ 0.021% BASE                          N77772 001  Sep 25, 2007    Se   NEWA
>A>   AN                                 EQ 0.042% BASE                          N77772 002  Sep 25, 2007    Se   NEWA

        AMLODIPINE BESYLATE
>A>       TABLET, ORALLY DISINTEGRATING; ORAL
>A>         AMLODIPINE BESYLATE
>A>           SYNTHON PHARMS             EQ 2.5MG BASE                           N22026 001  Sep 27, 2007    Se   NEWA
>A>                                      EQ 5MG BASE                             N22026 002  Sep 27, 2007    Se   NEWA
>A>       +                              EQ 10MG BASE                            N22026 003  Sep 27, 2007    Se   NEWA
          TABLET; ORAL
            AMLODIPINE BESYLATE
>A>   AB      WATSON LABS                EQ 2.5MG BASE                           N77073 001  Sep 26, 2007    Se   NEWA
>A>   AB                                 EQ 5MG BASE                             N77073 002  Sep 26, 2007    Se   NEWA
>A>   AB                                 EQ 10MG BASE                            N77073 003  Sep 26, 2007    Se   NEWA

>A>     AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
>A>       TABLET; ORAL
>A>         AZOR
>A>           DAIICHI SANKYO             EQ 5MG BASE;20MG                        N22100 001  Sep 26, 2007    Se   NEWA
>A>                                      EQ 5MG BASE;40MG                        N22100 002  Sep 26, 2007    Se   NEWA
>A>                                      EQ 10MG BASE;20MG                       N22100 003  Sep 26, 2007    Se   NEWA
>A>       +                              EQ 10MG BASE;40MG                       N22100 004  Sep 26, 2007    Se   NEWA

        AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE;
          TABLET; ORAL
            ADDERALL 10
>A>   AB      DURAMED RES                2.5MG;2.5MG;2.5MG;2.5MG                 N11522 007  Feb 13, 1996    Se   CAHN
>D>   AB      SHIRE                      2.5MG;2.5MG;2.5MG;2.5MG                 N11522 007  Feb 13, 1996    Se   CAHN
            ADDERALL 12.5
>A>   AB      DURAMED RES                3.125MG;3.125MG;3.125MG;3.125MG         N11522 012  Aug 31, 2000    Se   CAHN
>D>   AB      SHIRE                      3.125MG;3.125MG;3.125MG;3.125MG         N11522 012  Aug 31, 2000    Se   CAHN
            ADDERALL 15
>A>   AB      DURAMED RES                3.75MG;3.75MG;3.75MG;3.75MG             N11522 013  Aug 31, 2000    Se   CAHN
>D>   AB      SHIRE                      3.75MG;3.75MG;3.75MG;3.75MG             N11522 013  Aug 31, 2000    Se   CAHN
            ADDERALL 20
>A>   AB      DURAMED RES                5MG;5MG;5MG;5MG                         N11522 008  Feb 13, 1996    Se   CAHN
>D>   AB      SHIRE                      5MG;5MG;5MG;5MG                         N11522 008  Feb 13, 1996    Se   CAHN
            ADDERALL 30
>A>   AB  +   DURAMED RES                7.5MG;7.5MG;7.5MG;7.5MG                 N11522 010  May 12, 1997    Se   CAHN
>D>   AB  +   SHIRE                      7.5MG;7.5MG;7.5MG;7.5MG                 N11522 010  May 12, 1997    Se   CAHN
            ADDERALL 5
>A>   AB      DURAMED RES                1.25MG;1.25MG;1.25MG;1.25MG             N11522 009  May 12, 1997    Se   CAHN
>D>   AB      SHIRE                      1.25MG;1.25MG;1.25MG;1.25MG             N11522 009  May 12, 1997    Se   CAHN
            ADDERALL 7.5
>A>   AB      DURAMED RES                1.875MG;1.875MG;1.875MG;1.875MG         N11522 011  Aug 31, 2000    Se   CAHN
>D>   AB      SHIRE                      1.875MG;1.875MG;1.875MG;1.875MG         N11522 011  Aug 31, 2000    Se   CAHN

        ANAGRELIDE HYDROCHLORIDE
          CAPSULE; ORAL
            AGRYLIN
>D>   AB  +   SHIRE                      EQ 1MG BASE                             N20333 002  Mar 14, 1997    Se   DISC
>A>         @                            EQ 1MG BASE                             N20333 002  Mar 14, 1997    Se   DISC

        BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM
          TABLET, DELAYED RELEASE, FOR SOLUTION; ORAL
            HALFLYTELY
>A>       +   BRAINTREE                  5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.     N21551 002  Sep 24, 2007    Se   NEWA

        CALCIPOTRIENE
>D>       OINTMENT; TOPICAL
>D>         DOVONEX
>D>       +   LEO PHARM                  0.005%                                  N20273 001  Dec 29, 1993    Se   DISC
>A>         @                            0.005%                                  N20273 001  Dec 29, 1993    Se   DISC

        CARBOPLATIN
          INJECTABLE; INJECTION
            CARBOPLATIN
>D>   AP      PHARMACHEMIE               50MG/VIAL                               N76162 001  Oct 14, 2004    Se   CRLD
>A>   AP  +                              50MG/VIAL                               N76162 001  Oct 14, 2004    Se   CRLD
>D>   AP                                 150MG/VIAL                              N76162 002  Oct 14, 2004    Se   CRLD
>A>   AP  +                              150MG/VIAL                              N76162 002  Oct 14, 2004    Se   CRLD
>D>   AP                                 450MG/VIAL                              N76162 003  Oct 14, 2004    Se   CRLD
>A>   AP  +                              450MG/VIAL                              N76162 003  Oct 14, 2004    Se   CRLD
>D>         PARAPLATIN
>D>   AP  +   BRISTOL MYERS              50MG/VIAL                               N19880 001  Mar 03, 1989    Se   DISC
>A>         @                            50MG/VIAL                               N19880 001  Mar 03, 1989    Se   DISC
>D>   AP  +                              150MG/VIAL                              N19880 002  Mar 03, 1989    Se   DISC
>A>         @                            150MG/VIAL                              N19880 002  Mar 03, 1989    Se   DISC
>D>   AP  +                              450MG/VIAL                              N19880 003  Mar 03, 1989    Se   DISC
>A>         @                            450MG/VIAL                              N19880 003  Mar 03, 1989    Se   DISC
          INJECTABLE; IV (INFUSION)
            CARBOPLATIN
>D>   AP      PHARMACHEMIE               EQ 50MG/5ML (10MG/ML)                   N77269 001  Oct 14, 2004    Se   CRLD
>A>   AP  +                              EQ 50MG/5ML (10MG/ML)                   N77269 001  Oct 14, 2004    Se   CRLD
>D>   AP                                 EQ 150MG/15ML (10MG/ML)                 N77269 002  Oct 14, 2004    Se   CRLD
>A>   AP  +                              EQ 150MG/15ML (10MG/ML)                 N77269 002  Oct 14, 2004    Se   CRLD
>D>   AP                                 EQ 450MG/45ML (10MG/ML)                 N77269 003  Oct 14, 2004    Se   CRLD
>A>   AP  +                              EQ 450MG/45ML (10MG/ML)                 N77269 003  Oct 14, 2004    Se   CRLD
>D>   AP      TEVA PARENTERAL            EQ 50MG/5ML (10MG/ML)                   N77139 001  Sep 21, 2005    Se   CRLD
>A>   AP  +                              EQ 50MG/5ML (10MG/ML)                   N77139 001  Sep 21, 2005    Se   CRLD
>D>   AP                                 EQ 150MG/15ML (10MG/ML)                 N77139 002  Sep 21, 2005    Se   CRLD
>A>   AP  +                              EQ 150MG/15ML (10MG/ML)                 N77139 002  Sep 21, 2005    Se   CRLD
>D>   AP                                 EQ 450MG/45ML (10MG/ML)                 N77139 003  Sep 21, 2005    Se   CRLD
>A>   AP  +                              EQ 450MG/45ML (10MG/ML)                 N77139 003  Sep 21, 2005    Se   CRLD
>D>   AP                                 EQ 600MG/60ML (10MG/ML)                 N77139 004  Sep 21, 2005    Se   CRLD
>A>   AP  +                              EQ 600MG/60ML (10MG/ML)                 N77139 004  Sep 21, 2005    Se   CRLD

        CARISOPRODOL
>A>       TABLET; ORAL
>A>         SOMA
>A>           MEDPOINTE PHARM            250MG                                   N11792 004  Sep 13, 2007    Se   NEWA

        CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
          CAPSULE, EXTENDED RELEASE; ORAL
>A>         TUSSICAPS
>A>           TYCO HLTHCARE              EQ 4MG MALEATE;EQ 5MG                   N77273 002  Sep 24, 2007    Se   NEWA
>A>       +                              EQ 8MG MALEATE;EQ 10MG                  N77273 001  Sep 24, 2007    Se   NEWA

        CICLOPIROX
          SOLUTION; TOPICAL
>A>         CICLOPIROX
>A>   AT      ACTAVIS MID                8%                                      N78046 001  Sep 18, 2007    Se   NEWA
>A>   AT      APOTEX CORP                8%                                      N78172 001  Sep 18, 2007    Se   NEWA
>A>   AT      G AND W LABS               8%                                      N78233 001  Sep 18, 2007    Se   NEWA
>A>   AT      HI TECH PHARMA             8%                                      N78270 001  Sep 18, 2007    Se   NEWA
>A>   AT      PERRIGO NEW YORK           8%                                      N77623 001  Sep 18, 2007    Se   NEWA
>A>   AT      SYNERX PHARMA              8%                                      N78567 001  Sep 18, 2007    Se   NEWA
>A>   AT      TARO PHARM INDS            8%                                      N78144 001  Sep 18, 2007    Se   NEWA
>A>   AT      TEVA PHARMS                8%                                      N78079 001  Sep 18, 2007    Se   NEWA
>A>   AT      TOLMAR                     8%                                      N77687 001  Sep 18, 2007    Se   NEWA
>A>   AT      WATSON LABS                8%                                      N78124 001  Sep 18, 2007    Se   NEWA
            PENLAC
>D>       +   SANOFI AVENTIS US          8%                                      N21022 001  Dec 17, 1999    Se   CFTG
>A>   AT  +                              8%                                      N21022 001  Dec 17, 1999    Se   CFTG

        CLOPIDOGREL BISULFATE
          TABLET; ORAL
            PLAVIX
>A>           SANOFI AVENTIS US          EQ 300MG BASE                           N20839 002  Sep 20, 2007    Se   NEWA

        CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE
          SYRUP; ORAL
            PHENERGAN VC W/ CODEINE
>A>         @ ANI PHARMS                 10MG/5ML;5MG/5ML;6.25MG/5ML             N08306 005  Apr 02, 1984    Se   CAHN
>D>         @ WYETH AYERST               10MG/5ML;5MG/5ML;6.25MG/5ML             N08306 005  Apr 02, 1984    Se   CAHN

        CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PHENERGAN W/ CODEINE
>A>         @ ANI PHARMS                 10MG/5ML;6.25MG/5ML                     N08306 004  Apr 02, 1984    Se   CAHN
>D>         @ WYETH AYERST               10MG/5ML;6.25MG/5ML                     N08306 004  Apr 02, 1984    Se   CAHN

        CYANOCOBALAMIN
          SPRAY, METERED; NASAL
            CALOMIST
>D>         @ FLEMING                    25UGM/SPRAY                             N22102 001  Jul 27, 2007    Se   CMFD
>A>       +                              25UGM/SPRAY                             N22102 001  Jul 27, 2007    Se   CMFD

        DEXRAZOXANE HYDROCHLORIDE
          INJECTABLE; INJECTION
>D>         TOTECT
>A>         @ TOPOTARGET                 EQ 500MG BASE/VIAL                      N22025 001  Sep 06, 2007    Se   DISC

        DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PHENERGAN W/ DEXTROMETHORPHAN
>A>         @ ANI PHARMS                 15MG/5ML;6.25MG/5ML                     N11265 002  Apr 02, 1984    Se   CAHN
>D>         @ WYETH AYERST               15MG/5ML;6.25MG/5ML                     N11265 002  Apr 02, 1984    Se   CAHN

        ESTRADIOL VALERATE
          INJECTABLE; INJECTION
            DELESTROGEN
>D>       +   KING PHARMS                10MG/ML                                 N09402 002                  Se   CTEC
>A>   AO  +                              10MG/ML                                 N09402 002                  Se   CTEC
            ESTRADIOL VALERATE
>A>   AO      SANDOZ                     10MG/ML                                 N40628 001  Oct 04, 2007    Se   NEWA
>A>   AO                                 20MG/ML                                 N40628 002  Oct 04, 2007    Se   NEWA
>A>   AO                                 40MG/ML                                 N40628 003  Oct 04, 2007    Se   NEWA

        FERUMOXIDES
          INJECTABLE; INJECTION
            FERIDEX I.V.
>D>       +   ADV MAGNETICS              EQ 11.2MG IRON/ML                       N20416 001  Aug 30, 1996    Se   CAHN
>A>       +   AMAG PHARMS INC            EQ 11.2MG IRON/ML                       N20416 001  Aug 30, 1996    Se   CAHN

        FERUMOXSIL
          SUSPENSION; ORAL
            GASTROMARK
>D>       +   ADV MAGNETICS              EQ 0.175MG IRON/ML                      N20410 001  Dec 06, 1996    Se   CAHN
>A>       +   AMAG PHARMS INC            EQ 0.175MG IRON/ML                      N20410 001  Dec 06, 1996    Se   CAHN

        FLOXURIDINE
          INJECTABLE; INJECTION
            FLOXURIDINE
>D>   AP      BEDFORD                    500MG/VIAL                              N75387 001  Apr 16, 2000    Se   CRLD
>A>   AP  +                              500MG/VIAL                              N75387 001  Apr 16, 2000    Se   CRLD
>D>         FUDR
>D>   AP  +   HOSPIRA                    500MG/VIAL                              N16929 001                  Se   DISC
>A>         @                            500MG/VIAL                              N16929 001                  Se   DISC

        FLUDARABINE PHOSPHATE
          INJECTABLE; INJECTION
            FLUDARABINE PHOSPHATE
>A>   AP  +   EBEWE PHARMA               50MG/2ML(25MG/ML)                       N22137 001  Sep 21, 2007    Se   NEWA
>D>       +   TEVA PARENTERAL            50MG/2ML (25MG/ML)                      N76661 001  Apr 28, 2004    Se   CTEC
>A>   AP  +                              50MG/2ML (25MG/ML)                      N76661 001  Apr 28, 2004    Se   CTEC

        FLUDEOXYGLUCOSE F-18
          INJECTABLE; INTRAVENOUS
            FLUDEOXYGLUCOSE F18
>A>       +   FEINSTEIN                  20-200mCi/ML                            N21870 001  Aug 19, 2005    Se   CAHN
>D>       +   NORTH SHORE LIJ            20-200mCi/ML                            N21870 001  Aug 19, 2005    Se   CAHN

        GABAPENTIN
          CAPSULE; ORAL
            GABAPENTIN
>A>   AB      HIKMA                      100MG                                   N78150 001  Sep 25, 2007    Se   NEWA
>A>   AB                                 300MG                                   N78150 002  Sep 25, 2007    Se   NEWA
>A>   AB                                 400MG                                   N78150 003  Sep 25, 2007    Se   NEWA

        GADODIAMIDE
          INJECTABLE; INJECTION
            ONMISCAN
>A>       +   GE HEALTHCARE              14.35GM/50ML(287MG/ML)                  N22066 001  Sep 05, 2007    Se   NEWA
>A>       +                              28.7GM/100ML(287MG/ML)                  N22066 002  Sep 05, 2007    Se   NEWA

        HYDROCHLOROTHIAZIDE
          CAPSULE; ORAL
            HYDROCHLOROTHIAZIDE
>A>   AB      AUROBINDO                  12.5MG                                  N78164 001  Sep 18, 2007    Se   NEWA
          TABLET; ORAL
            HYDROCHLOROTHIAZIDE
>A>   AB      APOTEX                     25MG                                    N40774 001  Oct 03, 2007    Se   NEWA
>A>   AB                                 50MG                                    N40774 002  Oct 03, 2007    Se   NEWA
>A>   AB      LANNETT                    25MG                                    N84325 001                  Se   CMFD
>A>   AB                                 50MG                                    N84324 001                  Se   CMFD
>D>         @ PHARMERAL                  25MG                                    N84325 001                  Se   CMFD
>D>         @                            50MG                                    N84324 001                  Se   CMFD

        HYDROCORTISONE BUTYRATE
          CREAM; TOPICAL
            LOCOID
>D>   AB  +   FERNDALE LABS              0.1%                                    N18514 001  Mar 31, 1982    Se   CAHN
>A>   AB  +   TRIAX PHARMS               0.1%                                    N18514 001  Mar 31, 1982    Se   CAHN
            LOCOID LIPOCREAM
>D>       +   FERNDALE LABS              0.1%                                    N20769 001  Sep 08, 1997    Se   CAHN
>A>       +   TRIAX PHARMS               0.1%                                    N20769 001  Sep 08, 1997    Se   CAHN
          LOTION; TOPICAL
            LOCOID
>D>       +   FERNDALE LABS              0.1%                                    N22076 001  May 18, 2007    Se   CAHN
>A>       +   TRIAX PHARMS               0.1%                                    N22076 001  May 18, 2007    Se   CAHN
          OINTMENT; TOPICAL
            LOCOID
>D>   AB  +   FERNDALE LABS              0.1%                                    N18652 001  Oct 29, 1982    Se   CAHN
>A>   AB  +   TRIAX PHARMS               0.1%                                    N18652 001  Oct 29, 1982    Se   CAHN
          SOLUTION; TOPICAL
            LOCOID
>D>   AT  +   FERNDALE LABS              0.1%                                    N19116 001  Feb 25, 1987    Se   CAHN
>A>   AT  +   TRIAX PHARMS               0.1%                                    N19116 001  Feb 25, 1987    Se   CAHN

        HYDROMORPHONE HYDROCHLORIDE
          TABLET; ORAL
            HYDROMORPHONE HYDROCHLORIDE
>D>           KV PHARM                   2MG                                     N77311 001  Nov 09, 2005    Se   CTEC
>A>   AB                                 2MG                                     N77311 001  Nov 09, 2005    Se   CTEC
>D>                                      4MG                                     N77311 002  Nov 09, 2005    Se   CTEC
>A>   AB                                 4MG                                     N77311 002  Nov 09, 2005    Se   CTEC
>A>   AB      TYCO HLTHCARE              2MG                                     N78273 001  Sep 19, 2007    Se   NEWA
>A>   AB                                 4MG                                     N78273 002  Sep 19, 2007    Se   NEWA

        HYDROXYCHLOROQUINE SULFATE
          TABLET; ORAL
            HYDROXYCHLOROQUINE SULFATE
>A>   AB      ZYDUS PHARMS               200MG                                   N40657 001  Sep 21, 2007    Se   NEWA

        INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
          INJECTABLE; INJECTION
>A>         HUMALOG MIX 50/50 KWIKPEN
>A>       +   LILLY                      50 UNITS/ML;50 UNITS/ML                 N21018 002  Sep 06, 2007    Se   NEWA
>A>         HUMALOG MIX 75/25 KWIKPEN
>A>       +   LILLY                      75 UNITS/ML;25 UNITS/ML                 N21017 002  Sep 06, 2007    Se   NEWA

        INSULIN LISPRO RECOMBINANT
          INJECTABLE; INJECTION
>A>         HUMALOG KWIKPEN
>A>       +   LILLY                      100 UNITS/ML                            N20563 003  Sep 06, 2007    Se   NEWA

        LANTHANUM CARBONATE
          TABLET, CHEWABLE; ORAL
            FOSRENOL
>D>           SHIRE                      EQ 250MG BASE                           N21468 001  Oct 26, 2004    Se   DISC
>A>         @                            EQ 250MG BASE                           N21468 001  Oct 26, 2004    Se   DISC

        LEUCOVORIN CALCIUM
          INJECTABLE; INJECTION
            LEUCOVORIN CALCIUM
>D>   AP      BEDFORD                    EQ 50MG BASE/VIAL                       N89384 001  Sep 14, 1987    Se   CRLD
>A>   AP  +                              EQ 50MG BASE/VIAL                       N89384 001  Sep 14, 1987    Se   CRLD
>D>   AP                                 EQ 100MG BASE/VIAL                      N89717 001  Mar 28, 1988    Se   CRLD
>A>   AP  +                              EQ 100MG BASE/VIAL                      N89717 001  Mar 28, 1988    Se   CRLD

        LEVOTHYROXINE SODIUM
>D>       CAPSULE; ORAL
>D>         TIROSINT
>D>           INST BIOCHIMIQUE           0.013MG                                 N22121 001  Aug 01, 2007    Se   DISC
>A>         @                            0.013MG                                 N22121 001  Aug 01, 2007    Se   DISC
>D>                                      0.025MG                                 N21924 002  Oct 13, 2006    Se   DISC
>A>         @                            0.025MG                                 N21924 002  Oct 13, 2006    Se   DISC
>D>                                      0.05MG                                  N21924 003  Oct 13, 2006    Se   DISC
>A>         @                            0.05MG                                  N21924 003  Oct 13, 2006    Se   DISC
>D>                                      0.075MG                                 N21924 004  Oct 13, 2006    Se   DISC
>A>         @                            0.075MG                                 N21924 004  Oct 13, 2006    Se   DISC
>D>                                      0.1MG                                   N21924 005  Oct 13, 2006    Se   DISC
>A>         @                            0.1MG                                   N21924 005  Oct 13, 2006    Se   DISC
>D>                                      0.125MG                                 N21924 006  Oct 13, 2006    Se   DISC
>A>         @                            0.125MG                                 N21924 006  Oct 13, 2006    Se   DISC
>D>       +                              0.15MG                                  N21924 007  Oct 13, 2006    Se   DISC
>A>         @                            0.15MG                                  N21924 007  Oct 13, 2006    Se   DISC
          TABLET; ORAL
>D>         LEVOLET
>D>   BX      VINTAGE                    0.025MG                                 N21137 001  Jun 06, 2003    Se   DISC
>A>         @                            0.025MG                                 N21137 001  Jun 06, 2003    Se   DISC
>D>   BX                                 0.05MG                                  N21137 002  Jun 06, 2003    Se   DISC
>A>         @                            0.05MG                                  N21137 002  Jun 06, 2003    Se   DISC
>D>   BX                                 0.075MG                                 N21137 003  Jun 06, 2003    Se   DISC
>A>         @                            0.075MG                                 N21137 003  Jun 06, 2003    Se   DISC
>D>   BX                                 0.088MG                                 N21137 004  Jun 06, 2003    Se   DISC
>A>         @                            0.088MG                                 N21137 004  Jun 06, 2003    Se   DISC
>D>   BX                                 0.1MG                                   N21137 005  Jun 06, 2003    Se   DISC
>A>         @                            0.1MG                                   N21137 005  Jun 06, 2003    Se   DISC
>D>   BX                                 0.112MG                                 N21137 006  Jun 06, 2003    Se   DISC
>A>         @                            0.112MG                                 N21137 006  Jun 06, 2003    Se   DISC
>D>   BX                                 0.125MG                                 N21137 007  Jun 06, 2003    Se   DISC
>A>         @                            0.125MG                                 N21137 007  Jun 06, 2003    Se   DISC
>D>   BX                                 0.137MG                                 N21137 008  Jun 06, 2003    Se   DISC
>A>         @                            0.137MG                                 N21137 008  Jun 06, 2003    Se   DISC
>D>   BX                                 0.15MG                                  N21137 009  Jun 06, 2003    Se   DISC
>A>         @                            0.15MG                                  N21137 009  Jun 06, 2003    Se   DISC
>D>   BX                                 0.175MG                                 N21137 010  Jun 06, 2003    Se   DISC
>A>         @                            0.175MG                                 N21137 010  Jun 06, 2003    Se   DISC
>D>   BX                                 0.2MG                                   N21137 011  Jun 06, 2003    Se   DISC
>A>         @                            0.2MG                                   N21137 011  Jun 06, 2003    Se   DISC
>D>   BX                                 0.3MG                                   N21137 012  Jun 06, 2003    Se   DISC
>A>         @                            0.3MG                                   N21137 012  Jun 06, 2003    Se   DISC

        MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC;
          INJECTABLE; INJECTION
            ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
>D>           B BRAUN                    30MG/100ML;37MG/100ML;0.82MG/10         N19696 001  Sep 29, 1989    Se   CRLD
>A>       +                              30MG/100ML;37MG/100ML;0.82MG/10         N19696 001  Sep 29, 1989    Se   CRLD

        METHIMAZOLE
          TABLET; ORAL
            METHIMAZOLE
>A>   AB      CARACO                     5MG                                     N40870 001  Sep 25, 2007    Se   NEWA
>A>   AB                                 10MG                                    N40870 002  Sep 25, 2007    Se   NEWA

        METOPROLOL TARTRATE
          INJECTABLE; INJECTION
            METOPROLOL TARTRATE
>A>   AP      SANDOZ                     1MG/ML                                  N77360 001  Oct 02, 2007    Se   NEWA

        MINOCYCLINE HYDROCHLORIDE
          CAPSULE; ORAL
            MINOCIN
>D>   AB  +   TRIAX PHARMS               EQ 100MG BASE                           N50649 002  May 31, 1990    Se   CRLD
>A>   AB                                 EQ 100MG BASE                           N50649 002  May 31, 1990    Se   CRLD
            MINOCYCLINE HYDROCHLORIDE
>D>   AB      TEVA                       EQ 100MG BASE                           N63009 001  Mar 02, 1992    Se   CRLD
>A>   AB  +                              EQ 100MG BASE                           N63009 001  Mar 02, 1992    Se   CRLD

>D>     MORICIZINE HYDROCHLORIDE
>D>       TABLET; ORAL
>D>         ETHMOZINE
>D>           SHIRE                      200MG                                   N19753 001  Jun 19, 1990    Se   DISC
>A>         @                            200MG                                   N19753 001  Jun 19, 1990    Se   DISC
>D>                                      250MG                                   N19753 002  Jun 19, 1990    Se   DISC
>A>         @                            250MG                                   N19753 002  Jun 19, 1990    Se   DISC
>D>       +                              300MG                                   N19753 003  Jun 19, 1990    Se   DISC
>A>         @                            300MG                                   N19753 003  Jun 19, 1990    Se   DISC

        MORPHINE SULFATE
          INJECTABLE; INJECTION
            MORPHINE SULFATE
>D>   AP      MALLINCKRODT               1MG/ML                                  N20631 001  Jul 03, 1996    Se   DISC
>A>         @                            1MG/ML                                  N20631 001  Jul 03, 1996    Se   DISC
>D>       +                              2MG/ML                                  N20631 002  Jul 03, 1996    Se   DISC
>A>         @                            2MG/ML                                  N20631 002  Jul 03, 1996    Se   DISC
          TABLET, EXTENDED RELEASE; ORAL
            MORPHINE SULFATE
>A>   AB      KV PHARM                   100MG                                   N77855 001  Sep 27, 2007    Se   NEWA
>A>   AB                                 200MG                                   N77855 002  Sep 27, 2007    Se   NEWA

        NIFEDIPINE
          TABLET, EXTENDED RELEASE; ORAL
            NIFEDIPINE
>A>   AB2     OSMOTICA PHARM             90MG                                    N77410 001  Oct 03, 2007    Se   NEWA

        OFLOXACIN
          SOLUTION/DROPS; OTIC
            FLOXIN OTIC
>D>       +   DAIICHI                    0.3%                                    N20799 001  Dec 16, 1997    Se   CFTG
>A>   AT  +                              0.3%                                    N20799 001  Dec 16, 1997    Se   CFTG
>A>         OFLOXACIN
>A>   AT      APOTEX INC                 0.3%                                    N76527 001  Sep 28, 2007    Se   NEWA

        OXCARBAZEPINE
          TABLET; ORAL
>A>         OXCARBAZEPINE
>A>   AB      GLENMARK                   150MG                                   N77802 001  Oct 09, 2007    Se   NEWA
>A>   AB                                 300MG                                   N77802 002  Oct 09, 2007    Se   NEWA
>A>   AB                                 600MG                                   N77802 003  Oct 09, 2007    Se   NEWA
>A>   AB      ROXANE                     150MG                                   N77795 001  Oct 09, 2007    Se   NEWA
>A>   AB                                 300MG                                   N77795 002  Oct 09, 2007    Se   NEWA
>A>   AB                                 600MG                                   N77795 003  Oct 09, 2007    Se   NEWA
            TRILEPTAL
>D>           NOVARTIS                   150MG                                   N21014 001  Jan 14, 2000    Se   CFTG
>A>   AB                                 150MG                                   N21014 001  Jan 14, 2000    Se   CFTG
>D>                                      300MG                                   N21014 002  Jan 14, 2000    Se   CFTG
>A>   AB                                 300MG                                   N21014 002  Jan 14, 2000    Se   CFTG
>D>       +                              600MG                                   N21014 003  Jan 14, 2000    Se   CFTG
>A>   AB  +                              600MG                                   N21014 003  Jan 14, 2000    Se   CFTG

        PEMETREXED DISODIUM
          INJECTABLE; IV (INFUSION)
            ALIMTA
>A>       +   LILLY                      EQ 100MG BASE/VIAL                      N21462 002  Sep 07, 2007    Se   NEWA

        PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PHENERGAN VC
>A>         @ ANI PHARMS                 5MG/5ML;6.25MG/5ML                      N08604 003  Apr 02, 1984    Se   CAHN
>D>         @ WYETH AYERST               5MG/5ML;6.25MG/5ML                      N08604 003  Apr 02, 1984    Se   CAHN

        PRAMLINTIDE ACETATE
          INJECTABLE; SUBCUTANEOUS
            SYMLIN
>A>           AMYLIN                     EQ 1.5MG BASE/1.5ML (EQ 1MG             N21332 002  Sep 25, 2007    Se   NEWA
>A>                                      EQ 2.7MG BASE/2.7ML (EQ 1MG             N21332 003  Sep 25, 2007    Se   NEWA
>D>       +                              EQ 3MG BASE/5ML (EQ 0.6MG               N21332 001  Mar 16, 2005    Se   CPOT
>A>       +                              EQ 3MG BASE/5ML (EQ 600UGM              N21332 001  Mar 16, 2005    Se   CPOT

        PREDNISOLONE
          SYRUP; ORAL
            PREDNISOLONE
>A>   AA      VINTAGE                    15MG/5ML                                N40775 001  Sep 21, 2007    Se   NEWA


        PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PHENERGAN FORTIS
>A>         @ ANI PHARMS                 25MG/5ML                                N08381 003                  Se   CAHN
>D>         @ WYETH AYERST               25MG/5ML                                N08381 003                  Se   CAHN
            PHENERGAN PLAIN
>A>         @ ANI PHARMS                 6.25MG/5ML                              N08381 004  Apr 18, 1984    Se   CAHN
>D>         @ WYETH AYERST               6.25MG/5ML                              N08381 004  Apr 18, 1984    Se   CAHN

        QUININE SULFATE
          CAPSULE; ORAL
>A>         QUALAQUIN
>A>       +   AR HOLDING CO              324MG                                   N21799 001  Aug 12, 2005    Se   CTNA
>D>         QUININE SULFATE
>D>       +   AR HOLDING CO              324MG                                   N21799 001  Aug 12, 2005    Se   CTNA

        RANITIDINE HYDROCHLORIDE
          SYRUP; ORAL
            RANITIDINE HYDROCHLORIDE
>A>   AA      APOTEX                     EQ 15MG BASE/ML                         N77602 001  Sep 17, 2007    Se   NEWA
>A>   AA      PHARM ASSOC                EQ 15MG BASE/ML                         N77405 001  Sep 21, 2007    Se   NEWA

        RISEDRONATE SODIUM
          TABLET; ORAL
            ACTONEL
>D>           PROCTER AND                5MG                                     N20835 002  Apr 14, 2000    Se   CFTG
>A>   AB                                 5MG                                     N20835 002  Apr 14, 2000    Se   CFTG
>D>                                      30MG                                    N20835 001  Mar 27, 1998    Se   CFTG
>A>   AB                                 30MG                                    N20835 001  Mar 27, 1998    Se   CFTG
>D>       +                              35MG                                    N20835 003  May 25, 2002    Se   CFTG
>A>   AB  +                              35MG                                    N20835 003  May 25, 2002    Se   CFTG
>A>         RISEDRONATE SODIUM
>A>   AB      TEVA PHARMS                5MG                                     N77132 001  Oct 05, 2007    Se   NEWA
>A>   AB                                 30MG                                    N77132 002  Oct 05, 2007    Se   NEWA
>A>   AB                                 35MG                                    N77132 003  Oct 05, 2007    Se   NEWA

        SELEGILINE
          FILM, EXTENDED RELEASE; TRANSDERMAL
            EMSAM
>D>           SOMERSET                   6MG/24HR                                N21336 001  Feb 27, 2006    Se   CRLD
>A>       +                              6MG/24HR                                N21336 001  Feb 27, 2006    Se   CRLD
>D>       +                              12MG/24HR                               N21336 003  Feb 27, 2006    Se   CRLD
>A>                                      12MG/24HR                               N21336 003  Feb 27, 2006    Se   CRLD
        SODIUM POLYSTYRENE SULFONATE
          SUSPENSION; ORAL, RECTAL
>A>         KIONEX
>A>   AA      PADDOCK                    15GM/60ML                               N40028 001  Sep 17, 2007    Se   NEWA

        TERBINAFINE HYDROCHLORIDE
>A>       GRANULE; ORAL
>A>         LAMISIL
>A>           NOVARTIS                   EQ 125MG BASE/PACKET                    N22071 001  Sep 28, 2007    Se   NEWA
>A>       +                              EQ 187.5MG BASE/PACKET                  N22071 002  Sep 28, 2007    Se   NEWA

ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

None for this month.     

 

 
-